SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-098328
Filing Date
2016-02-12
Accepted
2016-02-12 20:46:02
Documents
1
Period of Report
2016-02-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4077
  Complete submission text file 0001209191-16-098328.txt   5447
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1500 WEST PARK DRIVE, SUITE 210 WESTBOROUGH MA 01581
Business Address
Kontulis Caitlin (Reporting) CIK: 0001570511 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36304 | Film No.: 161422256